Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 2 of 15 for:    molnupiravir

A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants With Severe Renal Impairment (MK-4482-003)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05386758
Recruitment Status : Recruiting
First Posted : May 23, 2022
Last Update Posted : August 9, 2022
Information provided by (Responsible Party):
Merck Sharp & Dohme LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 7, 2022
Estimated Study Completion Date : November 18, 2022